Key facts
- This page summarizes Jonathan D. Root's Form 4 filing for Silverback Therapeutics, Inc. (SPRY).
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 15 Dec 2021, 13:56.
Jonathan D. Root - 13 Dec 2021 Form 4 Insider Report for Silverback Therapeutics, Inc. (SPRY)
- Form type
- 4
- Accepted by SEC
- 15 Dec 2021, 13:56:24 UTC
- Previous filing
- 06 Dec 2021
- Next filing
- 28 Feb 2022
- SEC filing
- View on sec.gov
- Reporting owner signature
- Dale Holladay, Attorney in Fact for the Reporting Person
Source evidence
5 source fields
Reporting owner
1 detail
Key filing fact
Jonathan D. Root filed Form 4 for Silverback Therapeutics, Inc. (SPRY) on 15 Dec 2021.
Change
- Previous filing in this sequence was filed on 06 Dec 2021.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
See Original Filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
SPRY
transaction
Common Stock
Other
- Transaction value
- Shares
- -2,069,167
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 13 Dec 2021
- Ownership
- Directly owned by USVP XII
- Footnotes
- F1, F2
SPRY
transaction
Common Stock
Other
- Transaction value
- Shares
- -105,012
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 13 Dec 2021
- Ownership
- Directly owned by USVP XII-A
- Footnotes
- F1, F2
SPRY
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 95,238
- Date
- 13 Dec 2021
- Ownership
- Direct
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Represents a pro-rata, in-kind distribution by U.S. Venture Partners XII, L.P. ("USVP XII") and by U.S. Venture Partners XII-A, L.P. ("USVP XII-A"), without additional consideration, to its partners.
Footnote F2
Presidio Management Group XII, L.L.C. (PMG XII), the general partner of U.S. Venture Partners XII, L.P. and U.S. Venture Partners XII-A, L.P. (together, USVP XII), has sole voting and dispositive power with respect to the shares held by USVP XII. The reporting person is a managing member of PMG XII, and shares voting and dispositive power with respect to the shares held by USVP XII. The reporting person disclaims beneficial ownership of such holdings, except to the extent of his pecuniary interest in the shares.